CYH COMMUNITY HEALTH SYSTEMS INC
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1108109 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-7.8%
TTM net income YoY-89.1%
TTM EPS YoY-89.8%
Revenue 3-yr CAGR-2.2%
Net income 3-yr CAGR-46.5%
Margins
Gross margin85.5%
Operating margin10.9%
Net margin0.3%
FCF margin-1.0%
EBITDA margin14.6%
Returns
ROE—
ROA0.3%
ROIC (approx.)7.5%
Asset turnover0.92x
Leverage & solvency
Liabilities / assets107.7%
Debt / equity—
Current ratio1.48x
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.86x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $12.48B | $12.63B |
| Cost of revenue | $1.86B | $1.95B |
| Gross profit | $10.62B | $10.69B |
| Operating income | $1.49B | $542.00M |
| Pretax income | $724.00M | -$283.00M |
| Income tax | $48.00M | $79.00M |
| Net income | $509.00M | -$516.00M |
| EBITDA | $1.91B | $1.03B |
| EPS (basic) | 3.81 | -3.90 |
| EPS (diluted) | 3.77 | -3.90 |
| Weighted avg. shares (diluted) | 135.01M | 132.10M |
| Balance sheet | ||
| Cash & equivalents | $260.00M | $37.00M |
| Receivables | $2.08B | $2.29B |
| Current assets | $3.23B | $3.30B |
| PP&E, net | $4.50B | $4.78B |
| Goodwill | $3.32B | $3.79B |
| Intangibles | $7.00M | $15.00M |
| Total assets | $13.20B | $14.05B |
| Current liabilities | $2.21B | $2.35B |
| Short-term debt | $16.00M | $20.00M |
| Long-term debt | $10.38B | $11.43B |
| Total debt | $10.40B | $11.45B |
| Total liabilities | $14.04B | $15.37B |
| Shareholders' equity | -$1.39B | -$1.91B |
| Net debt | $10.14B | $11.41B |
| Shares outstanding | 138.63M | 138.92M |
| Cash flow statement | ||
| Operating cash flow | $543.00M | $480.00M |
| Capital expenditure | $335.00M | $360.00M |
| Free cash flow | $208.00M | $120.00M |
| Investing cash flow | $847.00M | -$275.00M |
| Financing cash flow | -$1.17B | -$206.00M |
| Depreciation & amortization | $426.00M | $486.00M |
| Stock-based compensation | $11.00M | $17.00M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.